TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33992615

Group type: EXPERIMENTAL
Intervention: Lipiflow treatment 3 weeks before cataract surgery
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group (no Lipiflow treatment)
Number of subjects: 124
Study: 36110574

Group type: EXPERIMENTAL
Intervention: Anti-PD-1 immunotherapy (sintilimab) combined with gemcitabine chemotherapy
Number of subjects: 32
Study: 34174189

Group type: EXPERIMENTAL
Intervention: Camrelizumab plus gemcitabine and cisplatin
Number of subjects: 263

Group type: COMPARATOR
Intervention: Placebo plus gemcitabine and cisplatin
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Camrelizumab
Number of subjects: 263

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 263
Study: 32438785

Group type: COMPARATOR
Intervention: Traditional Group (TG)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Intermittent Group (IG)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 103
Study: 36434335

Group type: EXPERIMENTAL
Intervention: TAVI with the balloon‐expandable Edwards Sapien 3
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: TAVI with the self‐expanding Medtronic Evolut R
Number of subjects: 447

Group type: COMPARATOR
Intervention: None/trivial PVR
Number of subjects: 447

Group type: COMPARATOR
Intervention: Trace PVR
Number of subjects: 447

Group type: COMPARATOR
Intervention: Mild PVR
Number of subjects: 447

Group type: COMPARATOR
Intervention: Moderate PVR
Number of subjects: 447

Group type: COMPARATOR
Intervention: Severe PVR
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Diastolic annular FD
Number of subjects: 447
Study: 34147766

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure plus Placebo (PE + PLB)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Sertraline plus Enhanced Medication Management (SERT + EMM)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure plus Sertraline (PE + SERT)
Number of subjects: 195
Study: 33150727

Group type: EXPERIMENTAL
Intervention: Homemade valved holding chamber (VHC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard commercial valved holding chamber (Aerochamber®)
Number of subjects: 20
Study: 35997590

Group type: EXPERIMENTAL
Intervention: Tuina
Number of subjects: 104

Group type: COMPARATOR
Intervention: Celecoxib
Number of subjects: 104
Study: 33393847

Group type: EXPERIMENTAL
Intervention: NMU76-F1 methylation
Number of subjects: 1160

Group type: EXPERIMENTAL
Intervention: GLR and lymphocyte numbers
Number of subjects: 1160
Study: 35610575

Group type: EXPERIMENTAL
Intervention: Water (5 mL/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: High-carbohydrate drink (5 mL/kg)
Number of subjects: 20
Study: 36196715

Group type: EXPERIMENTAL
Intervention: Thermal softening PVC double‐lumen tube (DLT)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Single‐lumen tube (SLT)
Number of subjects: 72
Study: 36048382

Group type: EXPERIMENTAL
Intervention: Aqueous extract of seed of broccoli, dosage and duration not available
Number of subjects: 0
Study: 33264737

Group type: EXPERIMENTAL
Intervention: Adapted Fresno Test
Number of subjects: 50
Study: 33140122

Group type: EXPERIMENTAL
Intervention: Ingestion of inorganic nitrate (NO3−); specific dosage and duration not mentioned.
Number of subjects: 0
Study: 34988975

Group type: EXPERIMENTAL
Intervention: Topical 5% 5-fluorouracil (5-FU)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Topical 5% imiquimod (IMIQ)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sunscreen (sun-protective factor 30+)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 5-FU
Number of subjects: 40
Study: 34639532

Group type: EXPERIMENTAL
Intervention: Standard 8-weeks MBSR training program
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Abbreviated 4-weeks MBSR training program
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 112
Study: 32164587

Group type: EXPERIMENTAL
Intervention: PEARL intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care as usual (control)
Number of subjects: 0
Study: 35180419

Group type: EXPERIMENTAL
Intervention: Whole blood
Number of subjects: 3188

Group type: COMPARATOR
Intervention: Packed cells
Number of subjects: 3188

Group type: COMPARATOR
Intervention: Settled cells
Number of subjects: 3188
Study: 34223142

Group type: EXPERIMENTAL
Intervention: Animated film intervention
Number of subjects: 417

Group type: COMPARATOR
Intervention: Control film
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Follow-up at 6 weeks
Number of subjects: 417
Study: 34742368

Group type: EXPERIMENTAL
Intervention: QFR-guided strategy (PCI performed only if QFR ≤0.80)
Number of subjects: 3825

Group type: COMPARATOR
Intervention: Angiography-guided strategy (PCI based on standard visual angiographic assessment)
Number of subjects: 3825
Study: 35932386

Group type: EXPERIMENTAL
Intervention: Formulation A
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Formulation A (fed condition)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Formulation A (multiple doses)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Formulation B
Number of subjects: 30
Study: 33113440

Group type: EXPERIMENTAL
Intervention: Dietary alpha-lipoic acid (ALA) supplementation (300 mg/kg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Basal diet (Control)
Number of subjects: 16
Study: 36175782

Group type: COMPARATOR
Intervention: Tofersen
Number of subjects: 0
Study: 33035141

Group type: EXPERIMENTAL
Intervention: Off-clamp surgery
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: On-clamp surgery
Number of subjects: 249

Group type: COMPARATOR
Intervention: Shift-on-clamp cases
Number of subjects: 249

Group type: COMPARATOR
Intervention: Shift-off-clamp cases
Number of subjects: 249

Group type: COMPARATOR
Intervention: On-clamp surgery per protocol
Number of subjects: 249
Study: 32274889

Group type: EXPERIMENTAL
Intervention: Primary radical radiotherapy, n=4,174
Number of subjects: 20350

Group type: EXPERIMENTAL
Intervention: Prostatectomy, n=1,210
Number of subjects: 20350

Group type: EXPERIMENTAL
Intervention: Men age 65-74
Number of subjects: 20350

Group type: EXPERIMENTAL
Intervention: All men with newly diagnosed locally advanced PCa
Number of subjects: 20350
Study: 36293952

Group type: EXPERIMENTAL
Intervention: e-Problem-Based Learning (e-PBL) program
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 54
Study: 32693097

Group type: EXPERIMENTAL
Intervention: Intervention clinics (clinician education sessions and electronic health record tools)
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Decision support tools (SmartSet and SmartText)
Number of subjects: 386

Group type: COMPARATOR
Intervention: Control clinics (no training or tools provided)
Number of subjects: 386
Study: 35244070

Group type: EXPERIMENTAL
Intervention: Nerve block therapy (NBT) + acupotomy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nerve block therapy (NBT)
Number of subjects: 50
Study: 34660811

Group type: EXPERIMENTAL
Intervention: Jinlida granules
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Combination treatment
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 138
Study: 34798147

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 266

Group type: COMPARATOR
Intervention: Minocycline and Celecoxib
Number of subjects: 266
Study: 36357855

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 124

Group type: COMPARATOR
Intervention: Nonsurgical care
Number of subjects: 124
Study: 32542836

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 33301047

Group type: EXPERIMENTAL
Intervention: Housing First (HF)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 87
Study: 33046465

Group type: EXPERIMENTAL
Intervention: Virtual Community of Practice (VCoP) for 12 months
Number of subjects: 250

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: VCoP
Number of subjects: 250
Study: 35028951

Group type: EXPERIMENTAL
Intervention: HD + SHF + HP
Number of subjects: 10

Group type: COMPARATOR
Intervention: High-volume postdilution olHDF
Number of subjects: 10
Study: 33336850

Group type: EXPERIMENTAL
Intervention: ADO09
Number of subjects: 24

Group type: COMPARATOR
Intervention: Lispro
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ins&Pram
Number of subjects: 24
Study: 32431275

Group type: EXPERIMENTAL
Intervention: Transfluthrin (spatial repellent)
Number of subjects: 1332

Group type: COMPARATOR
Intervention: Placebo (passive emanators)
Number of subjects: 1332
Study: 33778937

Group type: EXPERIMENTAL
Intervention: Refeeding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intraperitoneal glucose injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glutamate antagonist (CNQX + refeeding)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glutamate antagonist (CNQX + glucose)
Number of subjects: 0
Study: 33789971

Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT) - two sessions
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group - manipulations performed on a doll behind a screen
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Adjusted OMT
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 128
Study: 34392573

Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide topical solution 35% (H2 O2)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cryosurgery
Number of subjects: 15
Study: 35549757

Group type: EXPERIMENTAL
Intervention: Qingpeng ointment applied topically at involved joints twice a day for consecutive 7 days
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo ointment applied topically at involved joints twice a day for consecutive 7 days
Number of subjects: 206
Study: 33038078

Group type: EXPERIMENTAL
Intervention: Acupressure applied to CV‐23, SJ‐17, Kid‐1 acupuncture points for 15 min three times a week for six weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Acupressure applied to CV‐23, SJ‐17, Kid‐1 acupuncture points
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 60
Study: 32221093

Group type: EXPERIMENTAL
Intervention: SBRT with sorafenib
Number of subjects: 54

Group type: COMPARATOR
Intervention: SBRT alone
Number of subjects: 54
Study: 35351697

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided PENG block
Number of subjects: 92

Group type: COMPARATOR
Intervention: Ultrasound-guided femoral nerve block
Number of subjects: 92
Study: 32557634

Group type: EXPERIMENTAL
Intervention: Attentional bias toward affective pictorial stimuli
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Attentional bias
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (men without a history of criminal offending)
Number of subjects: 97
Study: 32098501

Group type: EXPERIMENTAL
Intervention: Exenatide 2 mg
Number of subjects: 14752

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14752

Group type: EXPERIMENTAL
Intervention: Any glucose-lowering medication
Number of subjects: 14752

Group type: EXPERIMENTAL
Intervention: Sulfonylurea
Number of subjects: 14752

Group type: EXPERIMENTAL
Intervention: All glucose-lowering medications
Number of subjects: 14752

Group type: EXPERIMENTAL
Intervention: Cardioprotective glucose-lowering agents
Number of subjects: 14752
Study: 36096147

Group type: EXPERIMENTAL
Intervention: RTS,S/AS01E malaria vaccine
Number of subjects: 0
Study: 33811730

Group type: EXPERIMENTAL
Intervention: Permanent polymer zotarolimus-eluting stent (PP-ZES)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Polymer-free amphilimus-eluting stent (PF-AES)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Permanent polymer zotarolimus-eluting stent (PP-ZES) in insulin-treated diabetics
Number of subjects: 304

Group type: COMPARATOR
Intervention: Polymer-free amphilimus-eluting stent (PF-AES) in insulin-treated diabetics
Number of subjects: 304
Study: 34705586

Group type: EXPERIMENTAL
Intervention: Progressive resistance exercise training (PRET) for 6 months
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: miR-19b-3p overexpression in human skeletal muscle cells in vitro
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Comparison of circulating and skeletal muscle miR-19b-3p expression between young and old mice
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Differential expression of six miRNAs (including miR-19b-3p) between Gainers and Losers
Number of subjects: 73
Study: 35123510

Group type: EXPERIMENTAL
Intervention: Macitentan treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34510021

Group type: EXPERIMENTAL
Intervention: Real-time visual feedback of the individual's own neck
Number of subjects: 23

Group type: COMPARATOR
Intervention: Observing a book
Number of subjects: 23
Study: 34505222

Group type: EXPERIMENTAL
Intervention: Transversus Abdominis Plane (TAP) block
Number of subjects: 174

Group type: COMPARATOR
Intervention: Local Wound Infiltration (LWI)
Number of subjects: 174
Study: 32145463

Group type: EXPERIMENTAL
Intervention: Processing of metric vs topological relations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Processing of exact vs co‐exact relations
Number of subjects: 0
Study: 33838078

Group type: EXPERIMENTAL
Intervention: Team Clinic (shared medical appointment model)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Traditional clinic visits (control group)
Number of subjects: 86
Study: 33080371

Group type: EXPERIMENTAL
Intervention: AED-equipped drone delivery
Number of subjects: 35

Group type: COMPARATOR
Intervention: Public access AED search
Number of subjects: 35
Study: 35543102

Group type: EXPERIMENTAL
Intervention: Etanercept (25 mg twice weekly for 16 weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 33535474

Group type: EXPERIMENTAL
Intervention: BRAINballs program (conducted twice a week)
Number of subjects: 55

Group type: COMPARATOR
Intervention: BRAINballs program
Number of subjects: 55
Study: 33218845

Group type: EXPERIMENTAL
Intervention: Biostimulant formulation 2 at a dosage of 0.25 kg ha-1
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Biostimulant formulations (F1, F2, F3) at dosages of 0.25, 0.50, and 1.0 kg ha-1
Number of subjects: 11

Group type: COMPARATOR
Intervention: Water-stressed control
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control without water deficit
Number of subjects: 11
Study: 32744035

Group type: EXPERIMENTAL
Intervention: Qizhukangxian granules (QG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 36448196

Group type: EXPERIMENTAL
Intervention: Older prisoner Health and Social Care Assessment and Plan (OHSCAP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 26
Study: 33653286

Group type: EXPERIMENTAL
Intervention: MultiMove intervention (dance-therapeutic component combined with motor-cognitive, strength, and flexibility exercises)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: MultiMove intervention
Number of subjects: 100
Study: 32472840

Group type: EXPERIMENTAL
Intervention: Brains Ahead! intervention (psychoeducational session with written take-home information and follow-up telephone call(s))
Number of subjects: 124

Group type: COMPARATOR
Intervention: Usual care (concise information brochure)
Number of subjects: 124
Study: 35608270

Group type: EXPERIMENTAL
Intervention: 4 mg/ml dilution of vancomycin
Number of subjects: 14

Group type: COMPARATOR
Intervention: 20 mg/ml dilution of vancomycin
Number of subjects: 14
Study: 36296983

Group type: EXPERIMENTAL
Intervention: Lactiplantibacillus plantarum OLL2712 (heat-treated cells)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 33207259

Group type: EXPERIMENTAL
Intervention: Brolucizumab
Number of subjects: 1817

Group type: COMPARATOR
Intervention: Aflibercept
Number of subjects: 1817
Study: 35073733

Group type: EXPERIMENTAL
Intervention: BEMPEG plus NIVO
Number of subjects: 0

Group type: COMPARATOR
Intervention: NIVO alone
Number of subjects: 0
Study: 33665685

Group type: EXPERIMENTAL
Intervention: Ertugliflozin (5 mg or 15 mg)
Number of subjects: 8246

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8246
Study: 33317565

Group type: EXPERIMENTAL
Intervention: Peanut protein (PP) supplement (75 total g powder providing 30 g protein, >9.2 g essential amino acids, 315 kcal; n=20)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control (CTL; no supplement; n=19)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Peanut protein (PP) supplement
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Peanut protein (PP) supplement (10-week group)
Number of subjects: 39
Study: 34837651

Group type: EXPERIMENTAL
Intervention: Whole peanut (WP)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Skinned peanut (SP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No peanut (NP)
Number of subjects: 24
Study: 32293438

Group type: EXPERIMENTAL
Intervention: Doctors
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Allied Health Professionals (AHPs)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Nurses
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: AHPs
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Nurses and AHPs
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Supervisors
Number of subjects: 360
Study: 33686147

Group type: EXPERIMENTAL
Intervention: MRI-based clinical-radiomic model
Number of subjects: 72
Study: 34373374

Group type: EXPERIMENTAL
Intervention: Double-guidewire technique with MagicTome (MDGT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Conventional double-guidewire technique (CDGT)
Number of subjects: 28
Study: 33465382

Group type: EXPERIMENTAL
Intervention: Abdominal massage using 'I LOV U' method along with lifestyle education, 15 min, twice daily for 10 days.
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Abdominal massage using 'I LOV U' method along with lifestyle education.
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 68
Study: 32860032

Group type: EXPERIMENTAL
Intervention: Icosapent ethyl (IPE) 4 g/day
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Icosapent ethyl (IPE)
Number of subjects: 80
Study: 35148442

Group type: EXPERIMENTAL
Intervention: Remote person-centred care (PCC) intervention conducted by health care professionals (HCPs)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Question-driven narrative sequences guided by the HCP
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Completed narrative sequences driven by the patient and collaborative narrative sequences
Number of subjects: 11
Study: 34853363

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (2000 IU/day cholecalciferol)
Number of subjects: 3424

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3424
Study: 34021915

Group type: EXPERIMENTAL
Intervention: IV dexamethasone (2 mL, 8 mg)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (2 mL IV solution)
Number of subjects: 37
Study: 32081056

Group type: EXPERIMENTAL
Intervention: Herbal combination
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 35306269

Group type: COMPARATOR
Intervention: Brief Intervention (BI)
Number of subjects: 440

Group type: COMPARATOR
Intervention: Combined Intervention (CoI)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Standard of Care (SOC)
Number of subjects: 440
Study: 33485354

Group type: EXPERIMENTAL
Intervention: Texas Sprouts intervention (n = 1412 children)
Number of subjects: 3135

Group type: COMPARATOR
Intervention: Control (delayed intervention, n = 1412 children)
Number of subjects: 3135

Group type: EXPERIMENTAL
Intervention: Texas Sprouts intervention
Number of subjects: 3135

Group type: COMPARATOR
Intervention: Control
Number of subjects: 3135
Study: 32866967

Group type: EXPERIMENTAL
Intervention: Metformin (2 g daily)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 262
Study: 35944104

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia using propofol (Group T)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Inhalation general anesthesia using sevoflurane (Group I)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (Group T and Group I)
Number of subjects: 60
Study: 33313898

Group type: EXPERIMENTAL
Intervention: Upadacitinib (UPA) monotherapy (15 mg, 30 mg)
Number of subjects: 1593

Group type: COMPARATOR
Intervention: MTX
Number of subjects: 1593
Study: 32745732

Group type: EXPERIMENTAL
Intervention: Smartphone application for medication adherence (6 months)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Smartphone application usage
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Secondary outcomes (not specified as intervention or control)
Number of subjects: 1000
Study: 33276251

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/salmeterol MDI HFA (250 μg/50 μg, twice daily)
Number of subjects: 231

Group type: COMPARATOR
Intervention: Fluticasone propionate/salmeterol DPI (500 μg/50 μg, twice daily)
Number of subjects: 231
Study: 33023473

Group type: EXPERIMENTAL
Intervention: Eptinezumab 100 mg
Number of subjects: 1072

Group type: EXPERIMENTAL
Intervention: Eptinezumab 300 mg
Number of subjects: 1072

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1072

Group type: EXPERIMENTAL
Intervention: Eptinezumab (both doses)
Number of subjects: 1072
Study: 35544095

Group type: COMPARATOR
Intervention: Dihydroartemisinin-piperaquine only
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine plus tafenoquine 0.42 mg/kg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine plus tafenoquine 0.83 mg/kg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine plus tafenoquine 1.66 mg/kg
Number of subjects: 80
Study: 35136296

Group type: EXPERIMENTAL
Intervention: Targeted fluid therapy (Group-T)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard fluid therapy (Group-S)
Number of subjects: 40
Study: 33026192

Group type: EXPERIMENTAL
Intervention: Support arm (clinicians endorsed and offered referral to a weight loss programme)
Number of subjects: 1882

Group type: EXPERIMENTAL
Intervention: Advice arm (advised that weight loss would improve health)
Number of subjects: 1882

Group type: COMPARATOR
Intervention: Both arms (support and advice)
Number of subjects: 1882